封面
市场调查报告书
商品编码
1448526

全球足底筋膜炎治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Plantar Fasciitis Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 178 Pages | 商品交期: 最快1-2个工作天内

价格

全球足底筋膜炎治疗市场的需求预计将从 2023 年的 8.3835 亿美元达到 2032 年的近 13.039 亿美元,2024-2032 年研究期间CAGR为 5.03%。

足底筋膜炎治疗涉及解决足底筋膜炎症,足底筋膜炎症是足部的厚组织带,会导致脚跟疼痛。治疗选择可能包括休息、物理治疗、伸展运动、矫形装置和抗发炎药物。

市场动态

足底筋膜炎治疗市场受到足部相关疾病发生率上升以及人们对有效治疗方案认识不断增强的影响。足底筋膜炎促使人们寻求治疗方法,从而推动了对各种治疗方式的需求。人口老化、体力活动增加以及运动相关伤害激增等因素促进了足底筋膜炎治疗市场的成长。创新疗法,包括衝击波疗法、矫形装置和再生医学方法,进一步扩大了可用的选择。此外,足底筋膜炎对日常生活和活动能力的影响促使人们探索和采用多样化的治疗解决方案,从而推动了足底筋膜炎治疗的整体市场。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球足底筋膜炎治疗市场的各个细分市场进行了包容性评估。足底筋膜炎治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

足底筋膜炎治疗市场报告的这一部分提供了国家和区域层面细分市场的详细资料,从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按类型

  • 药物治疗(口服、肠外)
  • 震波疗法(体外震波疗法(ESWT)、体内气动衝击波疗法(IPST))
  • 手术
  • 矫正器
  • 其他的

按最终用户

  • 医院
  • 诊所
  • 其他的

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲足底筋膜炎治疗市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。足底筋膜炎治疗市场的主要参与者包括 Hanger, Inc.、拜耳集团 (Scholl's)、A. Algeo Limited、Bauerfeind AG、Superfeet Worldwide, Inc.、Ottobock SE & Co. KGaA (Ottobock Holding)、辉瑞、公司、赛诺菲、葛兰素史克公司。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:足底筋膜炎治疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 最终用户的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球足底筋膜炎治疗市场分析:按类型

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 药物治疗(口服、肠外)
  • 震波疗法(体外震波疗法(ESWT)、体内气动衝击波疗法(IPST))
  • 手术
  • 矫正器
  • 其他的

第 6 章:全球足底筋膜炎治疗市场分析:依最终使用者分类

  • 最终用户概述
  • 历史和预测数据
  • 最终用户分析
  • 医院
  • 诊所
  • 其他的

第 7 章:全球足底筋膜炎治疗市场分析:依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章:足底筋膜炎治疗公司的竞争格局

  • 足底筋膜炎治疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Hanger Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bayer Group (Dr. Scholl's)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • A. Algeo Limited
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bauerfeind AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Superfeet Worldwide Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Ottobock SE & Co. KGaA (Ottobock Holding)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Pfizer Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Sanofi
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GlaxoSmithKline Plc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中,财务详细资讯和近期发展视情况而定,或者如果是私人公司,则可能不包括在内

Product Code: VMR112113821

The global demand for Plantar Fasciitis Treatment Market is presumed to reach the market size of nearly USD 1303.9 Million by 2032 from USD 838.35 Million in 2023 with a CAGR of 5.03% under the study period 2024 - 2032.

Plantar Fasciitis Treatment involves addressing plantar fascia inflammation which is a thick tissue band in the foot that causes heel pain. Treatment options may include rest, physical therapy, stretching exercises, orthotic devices, and anti-inflammatory medications.

MARKET DYNAMICS

The plantar fasciitis treatment market is influenced by the rising incidence of foot-related disorders and the growing awareness about effective treatment options. Plantar fasciitis prompts individuals to seek remedies, driving the demand for various treatment modalities. Factors such as an aging population, increased physical activity, and a surge in sports-related injuries contribute to the growth of the plantar fasciitis treatment market. Innovative treatments, including shockwave therapy, orthotic devices, and regenerative medicine approaches, further expand available options. Additionally, the impact of plantar fasciitis on daily life and mobility motivates individuals to explore and adopt diverse treatment solutions, boosting the overall market for plantar fasciitis treatments.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of plantar fasciitis treatment. The growth and trends of plantar fasciitis treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the plantar fasciitis treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Medication Therapy (Oral, Parenteral)
  • Shockwave Therapy (Extracorporeal Shock Wave Therapy (ESWT), Intracorporeal Pneumatic Shockwave Therapy (IPST))
  • Surgery
  • Orthotics
  • Others

By End-User

  • Hospitals
  • Clinics
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Plantar Fasciitis Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Plantar Fasciitis Treatment market include Hanger, Inc., Bayer Group (Dr. Scholl's), A. Algeo Limited, Bauerfeind AG, Superfeet Worldwide, Inc., Ottobock SE & Co. KGaA (Ottobock Holding), Pfizer, Inc., Sanofi, GlaxoSmithKline plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PLANTAR FASCIITIS TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By End-user
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PLANTAR FASCIITIS TREATMENT MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Medication Therapy (Oral, Parenteral) Historic and Forecast Sales by Regions
  • 5.5 Shockwave Therapy (Extracorporeal Shock Wave Therapy (ESWT), Intracorporeal Pneumatic Shockwave Therapy (IPST)) Historic and Forecast Sales by Regions
  • 5.6 Surgery Historic and Forecast Sales by Regions
  • 5.7 Orthotics Historic and Forecast Sales by Regions
  • 5.8 Others Historic and Forecast Sales by Regions

6 . GLOBAL PLANTAR FASCIITIS TREATMENT MARKET ANALYSIS BY END-USER

  • 6.1 Overview by End-user
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End-user
  • 6.4 Hospitals Historic and Forecast Sales by Regions
  • 6.5 Clinics Historic and Forecast Sales by Regions
  • 6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL PLANTAR FASCIITIS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE PLANTAR FASCIITIS TREATMENT COMPANIES

  • 8.1. Plantar Fasciitis Treatment Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF PLANTAR FASCIITIS TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Hanger Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Bayer Group (Dr. Scholl's)
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. A. Algeo Limited
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Bauerfeind AG
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Superfeet Worldwide Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Ottobock SE & Co. KGaA (Ottobock Holding)
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Pfizer Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Sanofi
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. GlaxoSmithKline Plc
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Medication Therapy (Oral, Parenteral) Market Sales by Geography (USD MN)
  • Shockwave Therapy (Extracorporeal Shock Wave Therapy (ESWT), Intracorporeal Pneumatic Shockwave Therapy (IPST)) Market Sales by Geography (USD MN)
  • Surgery Market Sales by Geography (USD MN)
  • Orthotics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Plantar Fasciitis Treatment Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Plantar Fasciitis Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Plantar Fasciitis Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Medication Therapy (Oral, Parenteral) Market Sales by Geography (USD MN)
  • Shockwave Therapy (Extracorporeal Shock Wave Therapy (ESWT), Intracorporeal Pneumatic Shockwave Therapy (IPST)) Market Sales by Geography (USD MN)
  • Surgery Market Sales by Geography (USD MN)
  • Orthotics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.